E. Schott
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 38
- Hepatitis C virus research 27
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Diseases and Immunity 3
- Hepatitis Viruses Studies and Epidemiology 2
- Epidemiology 20
- Liver Disease Diagnosis and Treatment 12
- Hepatitis B Virus Studies 11
- Co-authors
- Bruno Sangro (5 shared papers)Olivier Rosmorduc (4 shared papers)Damir Begic (2 shared papers)Philippe Mathurin (2 shared papers)Jaclyn Neely (2 shared papers)Thomas Chung Cheung Yau (2 shared papers)Masatoshi Kudo (2 shared papers)Su Pin Choo (2 shared papers)
- Journals
- Journal of Hepatology (21 papers)Annals of Oncology (4 papers)Journal of Viral Hepatitis (3 papers)JHEP Reports (1 paper)United European Gastroenterology Journal (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
E. Schott
42 papers receiving 1.1k citations
E. Schott's Hit Papers
Peers
Comparison fields: 5 of 65
- Hepatology 766
- Oncology 277
- Epidemiology 286
- Pathology and Forensic Medicine 131
- Immunology 139
Countries citing papers authored by E. Schott
This map shows the geographic impact of E. Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schott more than expected).
Fields of papers citing papers by E. Schott
This network shows the impact of papers produced by E. Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schott. The network helps show where E. Schott may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Schott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) Hit paper breakdown → | 2019 | 560 |
| 2 | 2017 | 133 | |
| 3 | 2007 | 66 | |
| 4 | 2020 | 53 | |
| 5 | 2017 | 42 | |
| 6 | 2018 | 34 | |
| 7 | 2022 | 18 | |
| 8 | 2011 | 18 | |
| 9 | 2022 | 16 | |
| 10 | 2011 | 15 | |
| 11 | 2019 | 12 | |
| 12 | 2015 | 11 | |
| 13 | 2018 | 10 | |
| 14 | 2005 | 9 | |
| 15 | 2011 | 8 | |
| 16 | 2014 | 8 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 6 | |
| 19 | 2016 | 5 | |
| 20 | Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection. | 2004 | 5 |
About E. Schott
E. Schott is a scholar working on Hepatology, Epidemiology, Oncology, Immunology and Genetics, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Hepatitis B Virus Studies (11 papers), Colorectal Cancer Treatments and Studies (3 papers), Liver Diseases and Immunity (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Hepatitis Viruses Studies and Epidemiology (2 papers). The work is most often cited by research in Hepatology (766 citations), Oncology (277 citations), Epidemiology (286 citations), Pathology and Forensic Medicine (131 citations) and Immunology (139 citations). E. Schott has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Bruno Sangro, Olivier Rosmorduc, Damir Begic, Philippe Mathurin, Jaclyn Neely, Thomas Chung Cheung Yau, Masatoshi Kudo, Su Pin Choo, Richard S. Finn and Robin Kate Kelley. Their work appears in journals such as Journal of Hepatology, Annals of Oncology, Journal of Viral Hepatitis, JHEP Reports and United European Gastroenterology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.